Neurol. praxi. 2025;26(1):68-71 | DOI: 10.36290/neu.2024.032

Cannabis as medicine

MUDr. Petra Mištríková
Neurologické oddělení, Vojenská nemocnice Brno

Hemp (Cannabis sativa) is a herb which was used for the production of canvas until the 19th century in Bohemia and Moravia. The progress in research focused on endocanabinoid system brings this herb into the focus again. Endocanabinoid system influences homeostasis of the whole organism due to modulation of neurotransmiter activity and subsequently the nociception, cognition, spasticity, sleep etc. Cannabinoid receptors are situated in the peripheral (CB2) and central nervous system (CB1), as well as in the connective tissue and immune system. The best-known effective molecules are delta-9-tetrahydrocanabinol (THC) and cannabidiol (CBD). I present a case report of a patient with chronic vertebrogenic problems and polyneuropathy of the lower extremities accompanied by neuropathic pain. Medical cannabis in monotherapy or in combination therapy can be a good choice for patients with neuropathic pain in individualized treatment.

Keywords: hemp, endocanabinoid system, cannabinoid receptors, THC, CBD, neuropathic pain.

Received: April 18, 2024; Revised: April 18, 2024; Accepted: May 6, 2024; Prepublished online: May 6, 2024; Published: March 19, 2025  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Mištríková P. Cannabis as medicine. Neurol. praxi. 2025;26(1):68-71. doi: 10.36290/neu.2024.032.
Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • PDF will be unlocked 19.3.2026

    References

    1. Alvarez LD, Carina Alves NR. Structural Basis for Molecular Recognition of Cannabinoids by Inhibitory Cys­‑Loop Channels. J Med Chem. 2024;67(5):3274-3286. doi: 10.1021/acs.jmedchem.3c02391. Epub 2024 Mar 1. PMID: 38428383. Go to original source... Go to PubMed...
    2. Crocq MA. History of cannabis and the endocannabinoid system. Dialogues Clin Neurosci. 2020;22(3):223-228. doi: 10.31887/DCNS.2020. 22. 3/mcrocq. PMID: 33162765; PMCID: PMC7605027. Go to original source...
    3. Cui Sun M, Otalora­‑Alcaraz A, Prenderville JA, et al.Toll­‑like receptor signalling as a cannabinoid target. Biochem Pharmacol. 2024;222:116082. doi: 10.1016/j.bcp.2024.116082. Epub ahead of print. PMID: 38438052. Go to original source... Go to PubMed...
    4. De Fatima Dos Santos Sampaio M, de Paiva YB, et al., Coimbra NC. Therapeutic applicability of cannabidiol and other phytocannabinoids in epilepsy, multiple sclerosis and Parkinson's disease and in comorbidity with psychiatric disorders. Basic Clin Pharmacol Toxicol. 2024 Mar 13. doi: 10.1111/bcpt.13997. Epub ahead of print. PMID: 38477419. Go to original source... Go to PubMed...
    5. Koob GF, Volkow ND, Neurobiology of addiction: a neurocircuitry analysis. Lancet Psychiatry. 2016;3:760-773. Go to original source... Go to PubMed...
    6. Kluwe L, Scholze C, Schmidberg LM, et al. Medical Cannabis Alleviates Chronic Neuropathic Pain Effectively and Sustainably without Severe Adverse Effect: A Retrospective Study on 99 Cases. Med Cannabis Cannabinoids. 2023;6(1):89-96. doi: 10.1159/000531667. PMID: 37900896; PMCID: PMC10601926. Go to original source... Go to PubMed...
    7. Landa L, Juřic J, et al. Léčebné konopí v současné medicínské praxi, Grada, 2020, ISBN 978-80-247-3967-0.
    8. Ligresti A, De Petrocellis L, Di Marzo V. From Phytocannabinoids to Cannabinoid Receptors and Endocannabinoids: Pleiotropic Physiological and Pathological Roles Through Complex Pharmacology. Physiol Rev. 2016;96(4):1593-659. doi: 10.1152/physrev.00002.2016. PMID: 27630175. Go to original source... Go to PubMed...
    9. Lu HC, Mackie K. Review of the Endocannabinoid System. Biol Psychiatry Cogn Neurosci Neuroimaging. 2021;6(6): 607-615. doi: 10.1016/j.bpsc.2020. 07. 016. Epub 2020 Aug 1. PMID: 32980261; PMCID: PMC7855189. Go to original source...
    10. McDonagh MS, Morasco BJ, Wagner J, et al. Cannabis­‑Based Products for Chronic Pain : A Systematic Review. Ann Intern Med. 2022175(8):1143-1153. doi: 10.7326/M21-4520. Epub 2022 Jun 7. PMID: 35667066. Go to original source... Go to PubMed...
    11. Mücke M, Phillips T, Radbruch L,et al. Cannabis­‑based medicines for chronic neuropathic pain in adults. Cochrane Database Syst Rev. 2018;3(3):CD012182. doi: 10.1002/14651858.CD012182.pub2. PMID: 29513392; PMCID: PMC6494210. Go to original source... Go to PubMed...
    12. Nelson K, Walsh D, Deeter P, et al. A phase II study of delta-9-tetrahydrocannabinol for appetite stimulation in cancer­‑associated anorexia. Journal Palliative Care. 1994;10:14-18. Go to original source...
    13. Pertwee RG; Pharmacology of cannabinoid CB1 a CB2 receptors. Pharmacology and Therapeutics. 1997;129-180. Go to original source... Go to PubMed...
    14. Schouten M, Dalle S, Mantini D, et al. Cannabidiol and brain function: current knowledge and future perspectives. Front Pharmacol. 2024;14:1328885. doi: 10.3389/fphar.2023.1328885. PMID: 38288087; PMCID: PMC10823027. Go to original source... Go to PubMed...
    15. Svizenska I, Dubovy P, Sulcova A. Cannabinoid receptors 1 and 2 (CB1 and CB2), their distribution, ligands and functional involvement in nervous systém structures­‑A short review. Pharmacology. Biochemistry and Behavior, 2008; 90: 501-511. Go to original source... Go to PubMed...
    16. Štětkářová I. a kol. Moderní farmakoterapie v neurologii, 2021, 3. rozšířené vydání, Maxdorf, ISBN 978-80-7345-706-8.
    17. Zhu C, Lan X, Wei Z, et al. Allosteric modulation of G protein­‑coupled receptors as a novel therapeutic strategy in neuropathic pain. Acta Pharm Sin B. 2024;14(1):67-86. doi: 10.1016/j.apsb.2023. 07. 020. Epub 2023 Jul 21. PMID: 38239234; PMCID: PMC10792987. Go to original source...
    18. Endokanabinoidní systém: Nahlédněme pod pokličku jeho fungování a možností; dostupné z: www.prolekare.cz.
    19. Informace pro lékaře Available from: www.sakl.cz.

    Return to the content


    Neurology for Practice

    Madam, Sir,
    please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
    Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

    I declare:

    1. that I have met the above instruction
    2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited

    No
    Yes

    If your statement is not true, please be aware
    that brings the risk of danger to their health or the health of others.